In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2264|57|4|182-191

ISSN： 1045-2257

Source： GENES, CHROMOSOMES AND CANCER, Vol.57, Iss.4, 2018-04, pp. : 182-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

By Chow Amy  

Journal of Mammary Gland Biology and Neoplasia, Vol. 16, Iss. 2, 2011-06 ,pp. : 81-88

Springer Publishing Company

Access to resources Recommend Favorite

Frequent Amplification of C-erbB2 (HER-2/Neu) Oncogene in Cervical Carcinoma as Detected by Non-Fluorescence in situ Hybridization Technique on Paraffin Sections

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 83-87

Karger

Access to resources Recommend Favorite

Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 3043-3051

John Wiley & Sons Inc

Access to resources Recommend Favorite

The ErbB2 Signaling Network as a Target for Breast Cancer Therapy

By Badache Ali   Gonçalves Anthony  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 13-25

Springer Publishing Company

Access to resources Recommend Favorite

Loss of ErbB2 Expression in Pulmonary Metastatic Lesions in Osteosarcoma

By  

Oncology, Vol. 60, Iss. 4, 2001-06 ,pp. : 361-366

Karger

Access to resources Recommend Favorite